Forte Biosciences, Inc.
FBRX
$17.00
$1.338.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.95M | 12.41M | 11.70M | 11.27M | 15.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.97M | 70.66M | 53.44M | 43.68M | 44.92M |
| Operating Income | -76.97M | -70.66M | -53.44M | -43.68M | -44.92M |
| Income Before Tax | -74.45M | -68.34M | -51.74M | -42.45M | -43.71M |
| Income Tax Expenses | 1.41M | 1.04M | -- | -- | -- |
| Earnings from Continuing Operations | -75.86 | -69.38 | -51.74 | -42.45 | -43.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.86M | -69.38M | -51.74M | -42.45M | -43.71M |
| EBIT | -76.97M | -70.66M | -53.44M | -43.68M | -44.92M |
| EBITDA | -76.90M | -70.59M | -53.38M | -43.64M | -44.88M |
| EPS Basic | -4.58 | -4.71 | -4.49 | -8.04 | -13.86 |
| Normalized Basic EPS | -2.80 | -2.90 | -2.81 | -5.03 | -8.66 |
| EPS Diluted | -4.58 | -4.71 | -4.49 | -8.04 | -13.86 |
| Normalized Diluted EPS | -2.80 | -2.90 | -2.81 | -5.03 | -8.66 |
| Average Basic Shares Outstanding | 65.27M | 58.80M | 47.06M | 31.12M | 21.22M |
| Average Diluted Shares Outstanding | 65.27M | 58.80M | 47.06M | 31.12M | 21.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |